Results 121 to 130 of about 38,429 (312)
Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar +10 more
wiley +1 more source
A randomized, double-blind, crossover study of the use of transcutaneous spinal electroanalgesia in patients with pain from chronic critical limb ischemia [PDF]
Karen H Simpson, Jason Ward
openalex +1 more source
New insights into epileptic spasm generation and treatment from the TTX animal model
Abstract Currently, we have an incomplete understanding of the mechanisms underlying infantile epileptic spasms syndrome (IESS). However, over the past decade, significant efforts have been made to develop IESS animal models to provide much‐needed mechanistic information for therapy development.
John W. Swann +2 more
wiley +1 more source
Excimer Laser Assisted Angioplasty for Critical Limb Ischemia: Results of the LACI Belgium Study [PDF]
Marc Bosiers +6 more
openalex +1 more source
Sulfated Polysaccharides in the Hallmarks of Metabolic Syndrome: Functions and Mechanisms
The SPs sources are very diverse, including various fishes, sea cucumbers, seaweeds, etc. These SPs are able to improve the glucose and lipid metabolism disorders, hormonal dysregulation, oxidative stress, inflammatory response, complications, and gut homeostasis of MetS by regulating biochemical indicators related to MetS. ABSTRACT Metabolic syndrome (
Fuqiang Zhao +9 more
wiley +1 more source
Diffuse dermal angiomatosis of the thigh as the presenting sign of critical limb ischemia. [PDF]
Pillai GS +4 more
europepmc +1 more source
Polysaccharides derived from medicine‐food plants restore intestinal barrier integrity and microbiota balance while modulating short‐chain fatty acid levels. These modifications significantly alleviate diabetes and its complications, including nephropathy, retinopathy, cardiovascular disease, and neuropathy.
Yi Long +13 more
wiley +1 more source

